Category Health/Medical

Engineered immune cells target and destroy glioblastoma in animal models

With a five-year survival rate of less than 5%, glioblastoma is one of the most aggressive types of brain cancer. Until now, all available treatments, including immunotherapy—which involves strengthening the immune system to fight cancer—have proved disappointing. CAR-T cells are genetically modified immune cells manufactured in the laboratory and designed to identify and destroy cancer cells.

By targeting a protein present in the tumor environment, a team from the University of Geneva (UNIGE) and the Geneva University Hospital (HUG) has developed CAR-T cells capable of destroying glioblastoma cells. Their efficacy in an animal model of the disease paves the way for clinical trials in humans.

The results are published in the Journal for ImmunoTherapy of Cancer.

Glioblasto...

Read More

Vision can be rebooted in adults with amblyopia, study suggests

MIT study shows how vision can be rebooted in adults with amblyopia
A new MIT study suggests a strategy for treating adults with amblyopia. Credit: Skitterphoto, CC0, via Wikimedia Commons

Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development and enables growth of responses to the amblyopic eye, new research shows.

In the common vision disorder amblyopia, impaired vision in one eye during development causes neural connections in the brain’s visual system to shift toward supporting the other eye, leaving the amblyopic eye less capable even after the original impairment is corrected. Current interventions are only effective during infancy and early childhood while the neural connections are still being formed.

But a new study in mice by neuroscientists in The Picower Institute f...

Read More

How a key protein helps drive healthy longevity by maintaining a precise balance

One foot on the gas and one on the brake: How a key protein helps drive healthy longevity
Illustration of the one-carbon metabolic pathway. Sirt6-dependent differentially acetylated proteins are highlighted by red circles. Credit: Proceedings of the National Academy of Sciences (2025). DOI: 10.1073/pnas.2514084122

Researchers at Bar-Ilan University have discovered how the longevity-associated protein Sirt6 orchestrates a delicate molecular balancing act that protects the body from age-related decline and disease. The new findings, just published in the Proceedings of the National Academy of Sciences, reveal how Sirt6 preserves health during aging and may pave the way for therapies that promote a longer, healthier life.

Sirt6, often described as a master regulator of aging, is known for its powerful protective effects against age-related diseases such as cancer, diabete...

Read More

Artificial neuron can mimic different parts of the brain—a major step toward human-like robotics

Scientists' artificial neuron can mimic different parts of the brain – a major step towards human-like robotics
An electronic chip used to create an artificial transneuron – a tiny electronic circuit that replicates how brain cells pass signals between one another by generating small electrical pulses. Credit: Loughborough University

Robots that can sense and respond to the world like humans may soon be a reality as scientists have created an artificial neuron capable of mimicking different parts of the brain.

Artificial neurons—tiny electronic circuits that replicate the way brain cells communicate—lie at the heart of neuromorphic computing, a field aiming to bring human-like intelligence to machines.

Despite rapid progress, today’s artificial neurons can only perform fixed tasks, each serving a narrow role...

Read More